Mical Paul

30.2k citations

320 papers · 16.3k indexed · 3 hit papers · h-index 70

Impact in

Applied Microbiology and Biotechnology top 0.02%
- Antibiotic Use and Resistance
Molecular Medicine top 0.02%
- Antibiotic Resistance in Bacteria

Papers in

Applied Microbiology and Biotechnology 64
- Antibiotic Use and Resistance 64
Molecular Medicine 67
- Antibiotic Resistance in Bacteria 67

Co-authors: Leonard Leibovici Dafna Yahav Anat Gafter‐Gvili Abigail Fraser Liat Vidal Tomer Avni Hefziba Green Adi Lador
Journals: Clinical Microbiology and Infection (45 papers)Cochrane Database of Systematic Reviews (36 papers)Journal of Antimicrobial Chemotherapy (33 papers)European Journal of Clinical Microbiology & Infectious Diseases (21 papers)Clinical Infectious Diseases (11 papers)
Partner nations: Israel United Kingdom Italy

In The Last Decade

Mical Paul

306 papers receiving 15.9k citations

Hit Papers

align trajectories log scale

Analysis of the clinical pipeline of treatments for drug resistant bacterial infections: despite progress, more action is needed. 2022 · 167 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2022 Oxford University Research Archive (ORA) (University of Oxford)
2020 Nature Reviews Microbiology
2019 Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy

Peers

Countries citing papers authored by Mical Paul

Since Specialization

Citations

This map shows the geographic impact of Mical Paul's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mical Paul with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mical Paul more than expected).

Fields of papers citing papers by Mical Paul

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mical Paul. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mical Paul. The network helps show where Mical Paul may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Mical Paul, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mical Paul Line = papers co-authored together Mical Paul links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Short vs. long antibiotic treatment for pyelonephritis and complicated urinary tract infections: a living systematic review and meta-analysis of randomized controlled trials Clinical Microbiology and Infection ·I Zahavi, Kelli Lampe, Kouichi Sugiyama, Xiaolong Bai, Mical Paul	2025	2
2	Carbapenem-resistant Enterobacterales acquisition following piperacillin-tazobactam versus carbapenem treatment: a propensity-matched cohort study Clinical Microbiology and Infection ·Hai Bin Chen, Mical Paul	2025	0
3	Seven vs Fourteen Days of Antibiotics for Gram-Negative Bloodstream Infection JAMA Network Open ·Todd C. Lee, Connor Prosty, Michael Fralick, Angela Huttner, Emily G. McDonald, José Molina, Mical Paul, Ruxandra Pinto, Kazuhiko Nakagawa, Elodie von Dach, Dafna Yahav, Saraswathi Uradi, Nick Daneman	2025	4
4	Clinical significance and burden of carbapenem-resistant Enterobacterales (CRE) colonization acquisition in hospitalized patients Antimicrobial Resistance and Infection Control ·Nasreen Hassoun‐Kheir, Mohamed Sharaf, 刘发建, M Chiarugi, F. Gottwald, L. L. Rybchik, Chan S. Park, Ávyla Régia de Albuquerque Barros, 姚明站, Sang Tran Kim, 新時代学校経営研究会, Mical Paul	2023	5
5	Predictors of infectious foci on FDG PET/CT in Staphylococcus aureus bacteremia Scientific Reports ·Nesrin Ghanem‐Zoubi, Xiaohua Zeng, Olga Kagna, 黃祏兢, 齐金堂, Daniel A. Haber, Mical Paul, Zohar Keidar	2023	1
6	Effectiveness and safety of colistin among older adults: a systematic review and meta-analysis Journal of Antimicrobial Chemotherapy ·Ili Margalit, Virginie Prendki, Ching Yeung Li, Marco Falcone, Giusy Tiseo, Yaara Leibovici‐Weissman, Mical Paul, Dafna Yahav, (unknown)	2022	6
7	Predicting In-Hospital Antibiotic Use in the Medical Department: Derivation and Validation Study Antibiotics ·Zainab A. Karamelahi, Meyer Elbaz, ‪Adi Turjeman‬‏, 손지한, Barbara Poiton, P. K. Shrivastava, Mical Paul, Leonard Leibovici	2022	1
8	Underrepresentation of women in randomized controlled trials: a systematic review and meta-analysis Trials ·Vered Daitch, ‪Adi Turjeman‬‏, Zainab A. Karamelahi, Noam Tau, SU Tian-cong, P. K. Shrivastava, Dafna Yahav, Mical Paul, Leonard Leibovici	2022	48
9	Predictors of Readmission Following Discharge of Patients With Gram-Negative Bacteremia: A Retrospective Cohort Study Open Forum Infectious Diseases ·M. F Coetsee, P. K. Shrivastava, Zainab A. Karamelahi, Mical Paul	2021	4
10	Inadequate reporting of participants eligible for randomized controlled trials – A systematic review and meta-analysis Journal of Clinical Epidemiology ·‪Adi Turjeman‬‏, Zainab A. Karamelahi, Vered Daitch, Noam Tau, SU Tian-cong, P. K. Shrivastava, Dafna Yahav, Mical Paul, Leonard Leibovici	2021	1
11	The Role of 18-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography (FDG-PET/CT) in Management of Nocardiosis: A Retrospective Study and Review of the Literature Infectious Diseases and Therapy ·Ili Margalit, Wasu Rattananurak, J.E. Aguayo C., Haim Ben‐Zvi, Caignaert Vincent, Elad Goldberg, Michal Weiler‐Sagie, Noam Tau, Khitam Muhsen, Jihad Bishara, Mical Paul, Hanna Bernstine, Dafna Yahav	2021	6
12	Direct on-the-spot detection of SARS-CoV-2 in patients Experimental Biology and Medicine ·E. García-Abascal, Ilia Naidanov, Tal Gefen, Tal Capucha, Haitham Hajjo, Ratna Dila, N. M. Lypkan, Peter Rogov, Daniel King, 欧亚梅, Assaf Rotem, Michal Chowers, Moran Szwarcwort‐Cohen, Mical Paul, Naama Geva‐Zatorsky	2020	32
13	Developing a new antibiotic for extensively drug-resistant pathogens: the case of plazomicin Clinical Microbiology and Infection ·Ursula Theuretzbacher, Mical Paul	2018	20
14	[REDUCTION OF ANTIBIOTIC CONSUMPTION IN RAMBAM HEALTH CARE CAMPUS - THE ROLE OF AN ANTIBIOTIC STEWARDSHIP PROGRAM]. PubMed ·Roni Bitterman, Ayelet Raz‐Pasteur, Zaher S. Azzam, Wm. Keighley Walton, Yishai Levy, Hossein Ghasemi, Eyal Braun, Ilana Oren, Yaron Bar‐Lavi, Imad Kassis, Khetam Hussein, Mical Paul	2017	4
15	Quantifying the associations between antibiotic exposure and resistance - a step towards personalised antibiograms European Journal of Clinical Microbiology & Infectious Diseases ·桜井薫, Mical Paul, Leonard Leibovici, Steen Andreassen	2016	11
16	STROBE-AMS: recommendations to optimise reporting of epidemiological studies on antimicrobial resistance and informing improvement in antimicrobial stewardship BMJ Open ·Evelina Tacconelli, Maria Adriana Cataldo, Mical Paul, Leonard Leibovici, Jan Kluytmans, Wiebke Schröder, Federico Foschi, Giulia De Angelis, Chiara de Waure, Chiara Cadeddu, Nico T. Mutters, Petra Gastmeier, B. Cookson	2016	55
17	Sternal wound infection after coronary artery bypass graft surgery: Validation of existing risk scores Journal of Thoracic and Cardiovascular Surgery ·Mical Paul, Aeyal Raz, Leonard Leibovici, Julia Moser, D. Pandal, Bina Rubinovitch	2007	62
18	Antibiotic prophylaxis in neutropenic patients. PubMed ·Anat Gafter‐Gvili, Mical Paul, Abigail Fraser, Leonard Leibovici	2007	8
19	Efficacy and safety of aminoglycoside monotherapy: systematic review and meta-analysis of randomized controlled trials Journal of Antimicrobial Chemotherapy ·Liat Vidal, Anat Gafter‐Gvili, Sara Borok, Abigail Fraser, Leonard Leibovici, Mical Paul	2007	108
20	Improving empirical antibiotic treatment: prospective, nonintervention testing of a decision support system Journal of Internal Medicine ·Leonard Leibovici, Adriano Dawison de Lima, Yoav Yehezkelli, افروز فرازنده مهر, Gai Milo, Mical Paul, Phillip Ein-Dor	1997	50

About Mical Paul

Mical Paul is a scholar working on Applied Microbiology and Biotechnology, Molecular Medicine, Clinical Biochemistry, Epidemiology and Infectious Diseases, having authored 320 papers that have together received 16.3k indexed citations. Recurring topics across this work include Bacterial Identification and Susceptibility Testing (83 papers), Antibiotic Resistance in Bacteria (67 papers), Antibiotic Use and Resistance (64 papers), Antibiotics Pharmacokinetics and Efficacy (55 papers), Neutropenia and Cancer Infections (44 papers), Pneumonia and Respiratory Infections (43 papers), Antimicrobial Resistance in Staphylococcus (27 papers) and Sepsis Diagnosis and Treatment (26 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (2.3k citations), Molecular Medicine (3.8k citations), Clinical Biochemistry (2.6k citations), Critical Care and Intensive Care Medicine (1.1k citations) and Infectious Diseases (3.4k citations). Mical Paul has collaborated with scholars based in Israel, United Kingdom and Italy. Frequent co-authors include Leonard Leibovici, Dafna Yahav, Anat Gafter‐Gvili, Abigail Fraser, Liat Vidal, Tomer Avni, Hefziba Green, Adi Lador, Elad Goldberg and Eyal Robenshtok. Their work appears in journals such as Clinical Microbiology and Infection, Cochrane Database of Systematic Reviews, Journal of Antimicrobial Chemotherapy, European Journal of Clinical Microbiology & Infectious Diseases and Clinical Infectious Diseases.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact